Presentation TCT 2018 Announcement: Introducing the Cath Lab Forum Presenter: Martina Kelly Speight September 21, 2018 REGISTER for free or LOG IN to view this content Policy & Practice Presentation TCT 2018 Cath Lab Up Next Presentation TCT 2018 TCT-13: 5-Year Outcomes From the Randomized Corevalve USPivotal High Risk Trial: Final Results Presenter: Thomas Gleason September 21, 2018 More slides + Presentation TCT 2018 TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve Presenter: Nicolas Dumontiel September 21, 2018 Presentation TCT 2018 TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial Presenter: Michael J. Reardon September 21, 2018 We Recommend
Presentation TCT 2018 TCT-13: 5-Year Outcomes From the Randomized Corevalve USPivotal High Risk Trial: Final Results Presenter: Thomas Gleason September 21, 2018
Presentation TCT 2018 TCT-14: Final 5-Year Outcomes Of The REPRISE II Study: Long-Term Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve Presenter: Nicolas Dumontiel September 21, 2018
Presentation TCT 2018 TCT-15: Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanically- versus Self-Expandable Valves: Results From The REPRISE III Randomized Trial Presenter: Michael J. Reardon September 21, 2018